Document is current
Any future updates will be listed below
-
Authors
Briggs, Mayen
Allinson, Kieren Simon James
Malpetti, Maura
Spillantini, Maria Grazia
Rowe, James Benedict
Kaalund, Sanne Simone https://orcid.org/0000-0002-8975-1825
-
Funding
Funding for this research was provided by:
Wellcome Trust (103838/Z/14/Z)
Medical Research Council (146281)
NIHR Cambridge Biomedical Research Centre (BRC-1215-20014)
Cambridge Centre for Parkinson-plus (RG95450)
- License Information
-
More Information
Article History
Received: 17 January 2021
Revised: 16 March 2021
Accepted: 16 March 2021
First Online: 28 March 2021
Declarations
:
: The authors declare that they have no conflict of interest.
: The study ethics was approved by the Health Research Authority, NHS, England (IRAS- 202 802, “Neurodegeneration Research in Dementia”). The PiPPIN (Pick's Disease and Progressive Supranuclear Palsy: Prevalence and Incidence) Study was approved by Cambridge's research ethics committee. The study was conducted in accordance with the 1964 Helsinki declaration.
